Filter
2394
Filtered Results: 2394
Text search:
widow
Featured
Recommendations
201
New Publications
752
Language
Document type
No document type
1483
Studies & Reports
332
Guidelines
268
Manuals
120
Training Material
57
Strategic & Response Plan
57
Fact sheets
31
Infographics
14
Situation Updates
13
Brochures
9
Resource Platforms
5
Online Courses
2
Videos
2
App
1
Countries / Regions
India
170
Kenya
86
Global
77
South Africa
62
Nepal
61
Ethiopia
55
Myanmar / Burma
53
Nigeria
52
Sierra Leone
51
Rwanda
48
Tanzania
47
Uganda
45
Zambia
41
Liberia
40
Western and Central Europe
38
Malawi
35
Syria
31
Zimbabwe
27
Bangladesh
27
Ghana
26
Philippines
25
Africa
25
Germany
25
Ukraine
23
Indonesia
22
Latin America and the Carribbean
21
Namibia
21
Lesotho
18
South Sudan
18
Congo, Democratic Republic of
17
Guinea
14
Cambodia
13
Eastern Europe
13
Brazil
13
Mozambique
12
Asia
12
West and Central Africa
12
Eswatini/ Swaziland
12
Botswana
11
Cameroon
10
Senegal
10
Burkina Faso
10
USA
9
Yemen
9
Afghanistan
8
Venezuela
8
Jordan
7
East and Southern Africa
7
Russia
7
South–East Asia Region
6
Vietnam
6
Moldova
6
Sudan
6
Mali
6
Somalia
6
Pakistan
6
Tajikistan
5
Middle East and North Africa
5
Lebanon
5
Central African Republic
5
Mexico
4
Niger
4
Haiti
4
Western Pacific Region
4
Sri Lanka
4
Benin
3
Laos
3
Peru
3
Eastern Europe and Central Asia
3
Paraguay
3
United Kingdom
3
Southern Africa
3
Egypt
3
Palestine
3
Libya
3
Iraq
3
Colombia
2
Turkey
2
Gambia
2
China
2
Chile
2
Albania
2
Singapore
2
Kyrgyzstan
2
Armenia
2
Gabon
2
Spain
2
Bosnia and Herzegovina
2
Bolivia
2
Papua New Guinea
2
Bhutan
2
Madagascar
2
Guatemala
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Thailand
1
Kazakhstan
1
Iran
1
Malaysia
1
Mongolia
1
Mauritania
1
Italy
1
Dominican Republic
1
Ireland
1
Turkmenistan
1
France
1
Portugal
1
Azerbaijan
1
Argentina
1
Djibouti
1
Romania
1
Greece
1
Poland
1
Honduras
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1025
Clinical Guidelines
128
Public Health
118
Key Resources
110
Women & Child Health
106
Capacity Building
53
Pharmacy & Technologies
28
Toolboxes
COVID-19
215
HIV
168
Mental Health
131
TB
111
Conflict
82
Rapid Response
76
Planetary Health
67
Disability
66
Ebola
64
Natural Hazards
63
Refugee
61
AMR
45
Caregiver
44
Zika
41
Pharmacy
40
NTDs
38
Global Health Education
28
Specific Hazards
27
NCDs
25
Health Financing Toolbox
22
Social Ethics
18
Polio
13
Cholera
6
Typhoon
1
In line with the Climate and Environment Charter for Humanitarian Organisations which IFRC, ICRC and various Red Cross Red Crescent National Societies have endorsed, this short Guide aims to help practitioners integrate environmental and climate change considerations into their work. It has been dev...
Health facilities in the Region of the Americas frequently suffer the effects of health emergencies and disasters, which jeopardize their ability to provide services to the population. The STAR-H methodology helps staff responsible for health emergency and disaster risk management to identify and as...
The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respond to the health and well-being challenges, opportunities and needs of adolescents.
The guidance pro...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
Infection prevention and control (IPC) in a CTC/ CTU IPC are all practical measures taken in the healthcare facility to prevent harm caused by infections to patients, health workers and communities.
The main goal of IPC in the cholera response is to
• To reduce transmission of health care-as...
Zimbabwe has, over the years, grappled with the repercussions of the climate crisis, which have led to erratic rainfall patterns characterized by either severe floods or prolonged periods of drought. The nation has experienced a concerning trend of numerous regions reporting rainfall levels below th...
This report shows that increased domestic revenues can and will cover only part of the necessary SDG budget spending of the LIDCs. Achieving the SDGs in the LIDCs will also require increases of both Official Development Assistance (ODA) and Private Development Assistance (PDA) to reach aggregate lev...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d...
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public health issue.
The World Health Organization (WHO) estimates that the number of cases reported worldwid...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
